who should not use tirzepatide Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study The hidden risks of GLP-1

Weekly injections require remembering once per week

Perez, R

Its modestly effective: weight loss up to 3-6% of total body weight is a significant result for many patients Less effective compared to new GLP-1 products: Mounjaro/Zepbound, Wegovy, and Ozempic lead to more weight loss Its not the most effective treatment for obesity: in case of bariatric surgery, weight loss will be 60-80% excess weight reduction, more effective by orders of magnitude compared to medications Lifelong drug therapy: otherwise youll regain your lost weight Trulicity might be a suitable weight loss product for patients with BMI less than 30 who need to lose 10-20 pounds

Occasional headaches may occur, especially during initial treatment phases as cellular detoxification processes increase activity